Sign In
Last checked at 
8 Jun 2026 11:59
08 June 2026
BSF Enterprise PLC
Result of General Meeting
BSF Enterprise PLC (LSE: BSFA) ("BSF" or the "Company"), a leading innovator in tissue-engineered materials, is pleased to announce that at the Company's General Meeting held earlier today, all resolutions proposed were duly passed by shareholders by way of a poll, the results of which were as follows:
Resolution | Shares | ||||
| For | % of votes | Against | % of votes | * Withheld |
Ordinary Resolution: 1. Directors' authority to allot shares for specific purposes | 38,811,710 | 97.35% | 1,057,257 | 2.65% | 94 |
Ordinary Resolution: 2. Directors' authority to allot shares for general purposes | 38,358,885 | 97.30% | 1,063,893 | 2.70% | 446,283 |
Special Resolution: 3. Disapplication of pre-emption rights for specific purposes | 38,809,545 | 97.34% | 1,059,422 | 2.66% | 94 |
Special Resolution: 4. Disapplication of pre-emption rights for general purposes | 38,345,356 | 97.27% | 1,077,422 | 2.73% | 446,283 |
A vote withheld is not a vote in law and is not counted in the calculation of the proportion of votes "For" or "Against" any of the Resolutions.
Following the passing of the Resolutions, an application has been made for 26,875,000 ordinary shares to be admitted to listing on the Equity Shares (transition) category of the Official List and to trading on the London Stock Exchange's main market for listed securities ("Admission") being 25,000,000 new ordinary shares pursuant to the Placing announced by the Company on 03 June in 2026 ("Placing Shares") and 1,875,000 new ordinary shares ("Fee Shares") in settlement of certain advisory fees.
It is expected that Admission of the Placing Shares and Fee Shares will become effective on or around 8.00 a.m. on 12 June 2026.
Total Voting Rights
Following Admission, the Company's enlarged share capital will comprise 193,749,437 ordinary shares of 1 penny each. Therefore, the total number of voting rights in the Company will be 193,749,437. This figure may be used by shareholders as the denominator for calculations by which they will determine if they are required to notify their interest in the Company, or a change to their interest in the Company, under the Financial Conduct Authority's Disclosure Guidance and Transparency Rules.
This announcement contains inside information for the purposes of Article 7 of Regulation 2014/596/EU which is part of domestic UK law pursuant to the Market Abuse (Amendment) (EU Exit) regulations (SI 2019/310).
END
Engage with the BSF Enterprise management team directly by asking questions, watching video summaries and seeing what other shareholders have to say. Navigate to our Interactive Investor website here:
https://bsfenterprise.com/link/ejnLne
For further enquiries, please visit www.bsfenterprise.com or contact:
BSF Enterprise PLC Geoff Baker - Chairman Che Connon - CEO & Director
We encourage all investors to share questions on this announcement via our investor website. | https://bsfenterprise.com/s/a1f22b |
Bowsprit Partners John Treacy James Sheehan |
+44 (0)203 883 4430 |
ISIN of the Ordinary Shares is GB00BHNBDQ51. SEDOL Code is BHNBDQ5. |
|
Subscribe to our news alert service: https://bsfenterprise.com/s/bb9f43
About BSF Enterprise PLC
BSF Enterprise PLC (LSE:BSFA) develops and commercialises cutting-edge tissue-engineered solutions, including lab-grown leather (via LGL), cultivated meat, and corneal repair technologies. By leveraging its proprietary scaffold-free ATEP™ platform, BSF delivers sustainable, high-performance alternatives to conventional materials, targeting global markets where provenance, ethics, and performance are increasingly prized by consumers and brands alike.
Follow the stocks
